163 related articles for article (PubMed ID: 30905708)
1. Polymorphs of Curcumin and Its Cocrystals With Cinnamic Acid.
Rathi N; Paradkar A; Gaikar VG
J Pharm Sci; 2019 Aug; 108(8):2505-2516. PubMed ID: 30905708
[TBL] [Abstract][Full Text] [Related]
2. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
Ober CA; Gupta RB
AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
[TBL] [Abstract][Full Text] [Related]
3. Fast dissolving eutectic compositions of curcumin.
Goud NR; Suresh K; Sanphui P; Nangia A
Int J Pharm; 2012 Dec; 439(1-2):63-72. PubMed ID: 23041131
[TBL] [Abstract][Full Text] [Related]
4. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
[TBL] [Abstract][Full Text] [Related]
5. Is Failure of Cocrystallization Actually a Failure? Eutectic Formation in Cocrystal Screening of Hesperetin.
Chadha K; Karan M; Chadha R; Bhalla Y; Vasisht K
J Pharm Sci; 2017 Aug; 106(8):2026-2036. PubMed ID: 28456725
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-assisted modulation of concomitant polymorphism of curcumin during liquid antisolvent precipitation.
Thorat AA; Dalvi SV
Ultrason Sonochem; 2016 May; 30():35-43. PubMed ID: 26703200
[TBL] [Abstract][Full Text] [Related]
7. Curcumin Cocrystal Micelles-Multifunctional Nanocomposites for Management of Neurodegenerative Ailments.
Desai PP; Patravale VB
J Pharm Sci; 2018 Apr; 107(4):1143-1156. PubMed ID: 29183742
[TBL] [Abstract][Full Text] [Related]
8. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
Liu J; Svärd M; Hippen P; Rasmuson ÅC
J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
[TBL] [Abstract][Full Text] [Related]
9. Supercritical CO
Sadeghi F; Kamali H; Kouhestanian S; Hadizadeh F; Nokhodchi A; Afrasiabi Garekani H
Pharm Dev Technol; 2022 Dec; 27(10):999-1008. PubMed ID: 36322612
[TBL] [Abstract][Full Text] [Related]
10. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA; Surov AO; Voronin AP; Drozd KV; Perlovich GL
Int J Pharm; 2021 Apr; 599():120441. PubMed ID: 33675927
[TBL] [Abstract][Full Text] [Related]
11. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
Qiu S; Li M
Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
[TBL] [Abstract][Full Text] [Related]
12. Impact of cocrystal solution-state stability on cocrystal dissociation and polymorphic drug recrystallization during dissolution.
Xuan B; Chen YCS; Wong KC; Chen R; Lo PS; Lakerveld R; Tong HHY; Chow SF
Int J Pharm; 2021 Dec; 610():121239. PubMed ID: 34742828
[TBL] [Abstract][Full Text] [Related]
13. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
Li Z; Matzger AJ
Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
[TBL] [Abstract][Full Text] [Related]
14. Quality by Design-Based Crystallization of Curcumin Using Liquid Antisolvent Precipitation: Micromeritic, Biopharmaceutical, and Stability Aspects.
Som S; Singh SK; Khatik GL; Kapoor B; Gulati M; Kuppusamy G; Anandhakrishnan NK; Kumar B; Yadav AK; Kumar R; Singh PK; Khursheed R; Kumar R; Pandey NK; Jyoti J; Mohanta S; Porwal O
Assay Drug Dev Technol; 2020 Jan; 18(1):11-33. PubMed ID: 31268345
[No Abstract] [Full Text] [Related]
15. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
Grossjohann C; Serrano DR; Paluch KJ; O'Connell P; Vella-Zarb L; Manesiotis P; Mccabe T; Tajber L; Corrigan OI; Healy AM
J Pharm Sci; 2015 Apr; 104(4):1385-98. PubMed ID: 25605031
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and n-acetylcysteine cocrystal produced with supercritical solvent: characterization, solubility, and preclinical evaluation of antinociceptive and anti-inflammatory activities.
Paulazzi AR; Alves BO; Zilli GAL; Dos Santos AE; Petry F; Soares KD; Danielli LJ; Pedroso J; Apel MA; Aguiar GPS; Siebel AM; Oliveira JV; Müller LG
Inflammopharmacology; 2022 Feb; 30(1):327-341. PubMed ID: 35006455
[TBL] [Abstract][Full Text] [Related]
18. Preparation, structural analysis, and properties of tenoxicam cocrystals.
Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
[TBL] [Abstract][Full Text] [Related]
19. Crystal engineering: co-crystals of cinnamic acid derivatives with a pyridyl derivative co-crystallizer.
Lorenzo DA; Forrest SJ; Sparkes HA
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Feb; 72(Pt 1):87-95. PubMed ID: 26830799
[TBL] [Abstract][Full Text] [Related]
20. Effect of stoichiometry upon the characteristics of quercetin-arginine cocrystals formulated through solution crystallization.
Mishra M; Agrawal S; Bahadur P; Tiwari S
Drug Dev Ind Pharm; 2024 Feb; 50(2):163-172. PubMed ID: 38226968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
